1.
Statins for the primary prevention of cardiovascular disease: caution required
by Casas, J. P
Journal of epidemiology and community health (1979), 2009-10, Vol.63 (Suppl 2), p.85-85
2.
Statin therapy in people with diabetes
by Kirby, Mike
Diabetes and primary care, 2012-03-01, Vol.14 (2), p.84
3.
Prevalence and predictors of clinically significant statin-drug interactions among Yemeni patients taking statins for primary and secondary prevention of cardiovascular disease
by Al-Ashwal, Fahmi Y.
Current medical research and opinion, 2022-06-03, Vol.38 (6), p.889-899
5.
Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study
by Valente, Roberto
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2018-06, Vol.18 (4), p.S53-S53
6.
Statin therapy in midlife women
by Shufelt, Chrisandra L.
Menopause (New York, N.Y.), 2021-07-19, Vol.28 (9), p.1067-1069
7.
Statins use and the risk of Acute Pancreatitis. A meta-analysis of observational studies
by Cárdenas Jaén, K
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2017-09, Vol.17 (5), p.S7-S7
8.
Inhalational exposure to statins and drug vehicle induces transient immunological changes in both the airways and peripheral blood of non-human primates
by Killingbeck, Sarah
Journal of allergy and clinical immunology, 2016, Vol.139 (2), p.AB266-AB266
9.
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
by Swerdlow, Daniel I, Dr
The Lancet (British edition), 2015-01-24, Vol.385 (9965), p.351-361
10.
Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohor...
by Jaén, Karina Cárdenas
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2018-06, Vol.18 (4), p.S92-S93
11.
Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
by Cederberg, Henna
Diabetologia, 2015-03-10, Vol.58 (5), p.1109-1117
12.
Effect for Coenzyme Q10 To Prevent Hepatic Injury from Atorvastatin and Rosuvastatin
by Xie, Ruiqin
The American journal of cardiology, 2013, Vol.111 (7), p.95B-95B
13.
Interpretation of the evidence for the efficacy and safety of statin therapy
by Collins, Rory, Prof
The Lancet (British edition), 2016, Vol.388 (10059), p.2532-2561
14.
Efficacy of Early IntensiveRosuvastatinTherapy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (ROSEMARY Study)
by Young-Guk Ko
The American journal of cardiology, 2014-07-01, Vol.114 (1), p.29
15.
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
by Fulcher, Jordan
The Lancet (British edition), 2015, Vol.385 (9976), p.1397-1405
16.
Statins: new American guidelines for prevention of cardiovascular disease
by Ridker, Paul M
The Lancet (British edition), 2013, Vol.382 (9907), p.1762-1765
17.
Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience
by Mampuya, Warner M., MD, PhD
The American heart journal, 2013, Vol.166 (3), p.597-603
18.
Statins and memory loss: An Australian experience
by Jamolowicz, Anna I
Australasian medical journal, 2015, Vol.8 (3), p.73-79
19.
Update on statin-mediated anti-inflammatory activities in atherosclerosis
by Montecucco, Fabrizio
Seminars in immunopathology, 2009-05-05, Vol.31 (1), p.127-142
20.
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
by Mihaylova, B
The Lancet (British edition), 2012, Vol.380 (9841), p.581-590
